These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14770105)

  • 1. [What does chronic hepatitis C steatosis mean?].
    Asselah T; Ripault MP; Marcellin P
    Gastroenterol Clin Biol; 2003 Dec; 27(12):1073-5. PubMed ID: 14770105
    [No Abstract]   [Full Text] [Related]  

  • 2. Steatosis in chronic hepatitis C: friend or foe?
    Negro F
    Liver Int; 2008 Mar; 28(3):294-6. PubMed ID: 18290771
    [No Abstract]   [Full Text] [Related]  

  • 3. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C and steatosis.
    Dev A; Patel K; McHutchison JG
    Clin Liver Dis; 2004 Nov; 8(4):881-92, ix. PubMed ID: 15464660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
    Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C and steatosis.
    Björnsson E; Angulo P
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history and predictors of disease severity in chronic hepatitis C.
    Massard J; Ratziu V; Thabut D; Moussalli J; Lebray P; Benhamou Y; Poynard T
    J Hepatol; 2006; 44(1 Suppl):S19-24. PubMed ID: 16356583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
    Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
    Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steatosis: co-factor in other liver diseases.
    Powell EE; Jonsson JR; Clouston AD
    Hepatology; 2005 Jul; 42(1):5-13. PubMed ID: 15962320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathology of chronic hepatitis C and its histological features].
    Shiga J; Fukusato T; Fukushima J
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):408-11. PubMed ID: 15359832
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C infection and nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
    Kurosaki M; Matsunaga K; Hirayama I; Tanaka T; Sato M; Komatsu N; Umeda N; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Asahina Y; Miyake S; Enomoto N; Izumi N
    J Hepatol; 2008 May; 48(5):736-42. PubMed ID: 18329125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
    Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.
    Fabris P; Floreani A; Carlotto A; Giordani MT; Baldo V; Stecca C; Marchioro L; Tramarin A; Bertin T; Negro F; de Lalla F
    J Hepatol; 2004 Oct; 41(4):644-51. PubMed ID: 15464246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-induced hepatocellular steatosis.
    Castera L; Chouteau P; Hezode C; Zafrani ES; Dhumeaux D; Pawlotsky JM
    Am J Gastroenterol; 2005 Mar; 100(3):711-5. PubMed ID: 15743372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic steatosis in Iranian patients with chronic hepatitis C.
    Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
    Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
    Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
    J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.